Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $43 | $43 | $45 | $39 |
| % Growth | 0.1% | -4.6% | 14.5% | – |
| Cost of Goods Sold | $25 | $26 | $26 | $20 |
| Gross Profit | $18 | $17 | $19 | $20 |
| % Margin | 41.3% | 40.1% | 42.3% | 50.1% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $8 | $9 | $8 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10 | $10 | $10 | $9 |
| Operating Income | $8 | $7 | $9 | $10 |
| % Margin | 17.9% | 17.4% | 19% | 26.3% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$1 |
| Pre-Tax Income | $7 | $6 | $8 | $9 |
| Tax Expense | $1 | $0 | $1 | $1 |
| Net Income | $6 | $6 | $7 | $8 |
| % Margin | 14.8% | 14% | 15.5% | 19.7% |
| EPS | 16.58 | 15.53 | 17.73 | 19.61 |
| % Growth | 6.8% | -12.4% | -9.6% | – |
| EPS Diluted | 16.53 | 15.45 | 17.64 | 19.46 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $2 | $1 | $1 | $1 |
| Depreciation & Amortization | $3 | $3 | $3 | $3 |
| EBITDA | $12 | $11 | $12 | $12 |
| % Margin | 27.5% | 26.1% | 26.6% | 30.5% |